title: Increases in Acute Hepatitis B Virus Infections - Kentucky, Tennessee, and West Virginia, 2006-2013.
abstract: As many as 2.2 million persons in the United States are chronically infected with hepatitis B virus (HBV) (1), and approximately 15%-25% of persons with chronic HBV infection will die prematurely from cirrhosis or liver cancer (2). Since 2006, the overall U.S. incidence of acute HBV infection has remained stable; the rate in 2013 was 1.0 case per 100,000 persons (3). Hepatitis B vaccination is highly effective in preventing HBV infection and is recommended for all infants (beginning at birth), all adolescents, and adults at risk for HBV infection (e.g., persons who inject drugs, men who have sexual contact with men, persons infected with human immunodeficiency virus [HIV], and others). Hepatitis B vaccination coverage is low among adults: 2013 National Health Interview Survey data indicated that coverage with ≥3 doses of hepatitis B vaccine was 32.6% for adults aged 19-49 years (4). Injection drug use is a risk factor for both hepatitis C virus (HCV) and HBV. Among young adults in some rural U.S. communities, an increased incidence of HCV infection has been associated with a concurrent increase of injection drug use (5); and recent data indicate an increase of acute HCV infection in the Appalachian region associated with injection drug use (6). Using data from the National Notifiable Diseases Surveillance System (NNDSS) during 2006-2013, CDC assessed the incidence of acute HBV infection in three of the four Appalachian states (Kentucky, Tennessee, and West Virginia) included in the HCV infection study (6). Similar to the increase of HCV infections recently reported, an increase in incident cases of acute HBV infection in these three states has occurred among non-Hispanic whites (whites) aged 30-39 years who reported injection drug use as a common risk factor. Since 2009, cases of acute HBV infection have been reported from more non-urban than urban regions. Evidence-based services to prevent HBV infection are needed.
authors.forename: Aaron M
authors.initials: AM
authors.lastname: Harris
authors.forename: Kashif
authors.initials: K
authors.lastname: Iqbal
authors.forename: Sarah
authors.initials: S
authors.lastname: Schillie
authors.forename: James
authors.initials: J
authors.lastname: Britton
authors.forename: Marion A
authors.initials: MA
authors.lastname: Kainer
authors.forename: Stacy
authors.initials: S
authors.lastname: Tressler
authors.forename: Claudia
authors.initials: C
authors.lastname: Vellozzi
mesh_terms: D000208:Acute Disease; D000328:Adult; D006509:Hepatitis B / Q000453:epidemiology*; D006801:Humans; D015994:Incidence; D007629:Kentucky / Q000453:epidemiology; D011159:Population Surveillance; D012307:Risk Factors; D015819:Substance Abuse, Intravenous / Q000453:epidemiology; D013714:Tennessee / Q000453:epidemiology; D014903:West Virginia / Q000453:epidemiology; D044465:White People / Q000706:statistics & numerical data